Buy-rated reports

588 tickers rated Buy
Ranks this page's recent reports by score.
BILL Holdings, Inc.
BILL·Technology
A ★★★★Buy
Current$47.82
Target$66.24
Return+38.5%
Aug 26, 2026

BILL has successfully transitioned from a hyper-growth cash-burner into a highly profitable, deeply undervalued free-cash-flow machine anchored by an impregnable SMB network, though investors must remain vigilant regarding intense competitive convergence from agile spend-management fintechs.

Score
88
Bandwidth Inc.
BAND·Communication Services
A ★★★★Buy
Current$47.52
Target$58.50
Return+23.1%
Aug 26, 2026

Bandwidth commands a highly defensible, owned-network CPaaS moat critical for enterprise AI voice orchestration, though investors must remain vigilant regarding the cyclical drag of political messaging and the looming specter of intense Twilio-led competition.

Score
85
Northern Oil and Gas, Inc.
NOG·Energy
A ★★★★Buy
Current$27.34
Target$29.88
Return+9.3%
Aug 26, 2026

Northern Oil and Gas is the undisputed, hyper-efficient non-operating consolidator of US shale, generating massive cash flow at a deeply distressed valuation, though investors must continuously monitor the vulnerability of its aggressive debt-funded acquisition pipeline.

Score
92
Minerals Technologies Inc.
MTX·Materials
A ★★★★Buy
Current$71.93
Target$94.50
Return+31.4%
Aug 25, 2026

Minerals Technologies is a highly profitable, cash-gushing specialty minerals monopoly trading at a severely distressed multiple, offering massive upside as it legally ring-fences its historic talc liabilities, though investors must remain vigilant regarding the secular decline of its legacy paper end-markets.

Score
85
Lucid Group, Inc.
LCID·Consumer Discretionary
A ★★★★Buy
Current$5.09
Target$27.00
Return+430.5%
Aug 25, 2026

Backed by unlimited sovereign capital and an elite technological moat, Lucid is successfully pivoting from a struggling luxury automaker into a high-volume autonomous infrastructure supplier for Uber.

Score
86
LeMaitre Vascular, Inc.
LMAT·Healthcare
A ★★★★Buy
Current$81.86
Target$107.00
Return+30.7%
Aug 25, 2026

LeMaitre Vascular is a highly profitable, cash-rich monopoly in the niche peripheral vascular market trading at a generational valuation floor, though investors must tolerate near-term volatility from international regulatory delays and temporary manufacturing consolidation costs.

Score
87
Slide Insurance Holdings, Inc.
SLDE·Financials
A ★★★★Buy
Current$23.52
Target$29.86
Return+27.0%
Aug 25, 2026

Slide Insurance leverages a proprietary tech stack to profitably underwrite coastal property insurance, trading at an exceptionally low multiple, though investors must weigh the inherent tail-risk of severe hurricane events against its massive reinsurance protections and robust cash generation.

Score
85
Custom Truck One Source, Inc.
CTOS·Industrials
A ★★★★Buy
Current$9.77
Target$13.33
Return+36.4%
Aug 25, 2026

Custom Truck One Source is an indispensable, deeply undervalued tollbooth for the multi-decade U.S. grid electrification supercycle, offering massive operational leverage and cash generation, provided management can successfully navigate the structural friction of its highly leveraged balance sheet.

Score
88
Keel Infrastructure Corp.
KEEL·Technology
A ★★★★Buy
Current$3.25
Target$6.15
Return+89.2%
Aug 25, 2026

Keel presents a rare, ground-floor opportunity to acquire deeply undervalued, scarce high-voltage power assets capable of generating massive recurring AI infrastructure yields, provided management can successfully navigate the severe execution risks of securing initial hyperscaler tenant commitments.

Score
85
Prestige Consumer Healthcare Inc.
PBH·Healthcare
A ★★★★Buy
Current$51.31
Target$66.70
Return+30.0%
Aug 25, 2026

Prestige Consumer Healthcare is a cash-printing tollbooth for indispensable niche consumer health brands trading at a deeply discounted multiple, though investors must monitor the successful integration of its massive Breathe Right acquisition and the rapid paydown of its elevated debt load.

Score
85
V2X, Inc.
VVX·Industrials
A ★★★★Buy
Current$78.50
Target$102.00
Return+29.9%
Aug 25, 2026

V2X is a highly entrenched, rapidly growing defense prime trading at a deep discount that will inevitably experience massive multiple expansion as it deleverages its balance sheet, though investors must tolerate near-term volatility stemming from structural accounts receivable timing delays.

Score
87
Skyward Specialty Insurance Group, Inc.
SKWD·Financials
A ★★★★Buy
Current$56.89
Target$75.00
Return+31.8%
Aug 25, 2026

Skyward Specialty offers an asymmetric risk-reward profile driven by top-quartile underwriting discipline, powerful fee-based expansion through Apollo, and a deeply discounted valuation relative to peers, though investors must diligently monitor execution risks tied to its aggressive shift into higher-loss-ratio casualty segments.

Score
94
Digi International Inc.
DGII·Technology
A ★★★★Buy
Current$74.91
Target$93.90
Return+25.4%
Aug 25, 2026

Digi International is successfully orchestrating a highly profitable transition from cyclical hardware to a sticky, high-margin software ecosystem, trading at a steep discount to software peers, though investors must monitor the balance sheet leverage accrued from its aggressive M&A strategy.

Score
92
GCM Grosvenor Inc.
GCMG·Financials
A ★★★★Buy
Current$13.80
Target$16.31
Return+18.2%
Aug 25, 2026

GCM Grosvenor is an established alternative asset manager accelerating its transition into highly profitable direct-oriented strategies at a heavily discounted valuation, though investors must navigate concentrated performance-fee risks tied to its massive unrealized SpaceX position.

Score
86
Trekor Metals Limited
TGB·Materials
A ★★★★Buy
Current$9.19
Target$12.00
Return+30.6%
Aug 25, 2026

Trekor Metals offers highly leveraged, fully funded exposure to the secular copper supercycle through its proprietary, low-cost ISCR extraction technology, provided investors can tolerate the inherent volatility of cyclical commodity markets.

Score
87
TransMedics Group, Inc.
TMDX·Healthcare
A ★★★★Buy
Current$94.77
Target$127.62
Return+34.7%
Aug 25, 2026

TransMedics is systematically transforming the $10 billion global organ transplant market through an unassailable, vertically integrated aviation and technology monopoly, offering massive upside as it targets the kidney segment, though investors must tolerate severe near-term margin compression as the company aggressively scales its European infrastructure.

Score
85
Tarsus Pharmaceuticals, Inc.
TARS·Healthcare
A ★★★★Buy
Current$72.70
Target$100.00
Return+37.6%
Aug 25, 2026

Tarsus is operating an explosive, cash-flowing commercial monopoly in eye care at a deeply discounted valuation, though investors must closely monitor the execution risks tied to its aggressive, half-billion-dollar clinical pipeline acquisitions.

Score
91
Beacon Financial Corporation
BBT·Financials
A ★★★★Buy
Current$31.65
Target$36.80
Return+16.3%
Aug 25, 2026

Beacon Financial is a highly profitable, structurally cheap regional banking fortress that has fully conquered its merger-integration hurdles to unleash explosive margin expansion, though investors must vigilantly monitor its exposure to localized commercial real estate credit cycles.

Score
87
Alarm.com Holdings, Inc.
ALRM·Technology
A ★★★★Buy
Current$57.51
Target$70.00
Return+21.7%
Aug 25, 2026

Alarm.com operates an elite, cash-gushing B2B SaaS monopoly in the professional smart property sector trading at a deep historical discount, successfully utilizing explosive commercial and energy software growth to entirely outrun the structural headwinds of ADT's transition and macroeconomic hardware tariff volatility.

Score
86
Kaiser Aluminum Corporation
KALU·Materials
A ★★★★Buy
Current$154.16
Target$184.95
Return+20.0%
Aug 25, 2026

Kaiser Aluminum is a deeply entrenched, highly profitable metallurgical converter positioned for explosive margin expansion as its packaging and aerospace investments hit full utilization, though investors must diligently monitor the persistent, macro-induced demand destruction within its automotive extrusion segment.

Score
86
The Chemours Company
CC·Materials
A ★★★★Buy
Current$15.97
Target$23.64
Return+48.0%
Aug 24, 2026

Chemours is a deeply discounted, highly profitable tollbooth for the global low-GWP refrigerant transition and AI data center cooling boom, though investors must tolerate extreme optical volatility caused by cyclical housing headwinds and legacy litigation cash drains.

Score
86
Nicolet Bankshares, Inc.
NIC·Financials
A ★★★★Buy
Current$173.23
Target$194.00
Return+12.0%
Aug 24, 2026

Nicolet Bankshares leverages disciplined M&A and relationship banking to generate peer-leading profitability, demonstrating exceptional margin expansion and an aggressive buyback strategy that firmly solidifies its status as a premier regional compounder.

Score
87
Grindr Inc.
GRND·Technology
A ★★★★Buy
Current$15.10
Target$20.50
Return+35.8%
Aug 24, 2026

Grindr is a highly profitable, monopolistic tollbooth for global LGBTQ+ social connection, trading at an undemanding cash-flow multiple given its 33% revenue growth, though investors must monitor the ongoing suppression of user acquisition driven by international age-verification mandates.

Score
86
The Andersons, Inc.
ANDE·Consumer Staples
A ★★★★Buy
Current$68.06
Target$95.00
Return+39.6%
Aug 24, 2026

Andersons is an overlooked, deeply undervalued supply-chain powerhouse successfully pivoting into highly lucrative renewable fuels, though investors must remain vigilant regarding its heavy reliance on federal low-carbon tax incentives.

Score
85